Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Relaxin-like factor and relaxin analogues described

Feb. 21, 1997

Akzo reports peptides for specific tolerance therapy

Feb. 20, 1997

SKB prepares cytokine inhibitors

Feb. 19, 1997

University of California researchers report pseudopterosin derivatives

Feb. 19, 1997

Inhibitors of cell adhesion disclosed by Tanabe

Feb. 18, 1997

MGI Pharma seeks FDA approval of new indication for Salagen Tablets

Feb. 12, 1997

Arthritis gene therapy appears to hold promise

Feb. 12, 1997

Selective gelatinase inhibitor described by British Biotech

Feb. 11, 1997

Meiji Milk discloses new gold complex

Feb. 10, 1997

New use of ciclosporin recommended for approval

Feb. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...